NASDAQ : RPID
Rapid Micro Biosystems, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.7359 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 36.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 37.43M |
| Enterprise Value | 40.41M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 45.66M |
| Shares Outstanding | 50.16M |
| Shares Change (YoY) | +4.55% |
| Shares Change (QoQ) | +6.41% |
| Owned by Insiders (%) | 3.03% |
| Owned by Institutions (%) | 18.15% |
| Float | 23.91M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.05 |
| Forward PS | 0.86 |
| PB Ratio | 2.07 |
| P/TBV Ratio | 2.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.55 |
| Quick Ratio | 1.43 |
| Debt / Equity | 1.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.16 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -141.65% |
| Return on Assets (ROA) | -46.40% |
| Return on Invested Capital (ROIC) | -61.37% |
| Return on Capital Employed (ROCE) | -123.47% |
| Weighted Average Cost of Capital (WACC) | 10.63% |
| Revenue Per Employee | $205,708 |
| Profits Per Employee | -$299,415 |
| Employee Count | 171 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.68 |
Taxes
| Measure | Value |
|---|
| Income Tax | 75,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.48 |
| 52-Week Price Change | -74.36% |
| 50-Day Moving Average | 1.09 |
| 200-Day Moving Average | 2.24 |
| Relative Strength Index (RSI) | 26.37 |
| Average Volume (20 Days) | 168,791 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 888,578 |
| Short Previous Month | 853,972 |
| Short % of Shares Out | 1.77% |
| Short % of Float | 3.72% |
| Short Ratio (days to cover) | 2.90 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 35.18M |
| Gross Profit | 1.95M |
| Operating Income | -49.76M |
| Pretax Income | -51.13M |
| Net Income | -51.20M |
| EBITDA | -47.08M |
| EBIT | -49.76M |
| Loss Per Share | -$1.11 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 20.50M |
| Total Debt | 23.48M |
| Net Cash | -2.98M |
| Net Cash Per Share | -$0.06 |
| Equity (Book Value) | 17.75M |
| Book Value Per Share | 0.36 |
| Working Capital | 28.11M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -40.06M |
| Capital Expenditures | -336,000 |
| Depreciation & Amortization | 2.67M |
| Net Borrowing | 19.97M |
| Free Cash Flow | -40.39M |
| FCF Per Share | -$0.81 |
Margins
| Measure | Value |
|---|
| Gross Margin | 5.55% |
| Operating Margin | -141.45% |
| Pretax Margin | -145.34% |
| Profit Margin | -145.55% |
| EBITDA Margin | -133.85% |
| EBIT Margin | -141.45% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.55% |
| Shareholder Yield | -4.55% |
| Earnings Yield | -149.07% |
| FCF Yield | -109.43% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.75 |
| Price Target Difference | 670.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 21.51% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -12.75 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |